Triveni Bio

About:

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Website: https://triveni.bio

Top Investors: OrbiMed, Alexandria Venture Investments, Fidelity, Cormorant Asset Management, Invus

Description:

Triveni Bio is a biotech company advancing novel antibody treatments for I&I disorders. Using a genetics-driven precision medicine approach, the company aims to demonstrate proof-of-concept early in drug development by harnessing deep insights into genetic and mechanistic biology. The company's drug discovery platform aims to create targeted therapies for immunological and inflammatory diseases.

Total Funding Amount:

$207M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

ops(AT)triveni.bio

Founders:

Leonard Zon, Tillman Gerngross

Number of Employees:

11-50

Last Funding Date:

2024-10-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai